首页> 美国卫生研究院文献>Cardiology and Therapy >Transcatheter Pulmonary Valve Replacement
【2h】

Transcatheter Pulmonary Valve Replacement

机译:经导管肺动脉瓣置换

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transcatheter pulmonary valve replacement (tPVR) has evolved into a viable alternative to surgical conduit or bioprosthetic valve replacement. This procedure has paved the way for a more advanced approach to congenital and structural interventional cardiology. Although many successes have been noted, there are still a number of challenges with this procedure, including large delivery systems, the need for a conduit or a bioprosthetic valve as a landing zone for the valve, optimal timing of the procedure to prevent right ventricular failure, arrhythmias, and possible death. Research is ongoing to broaden the use of this technology when treating patients with dilated right ventricular outflow tracts, and early experience with a self-expanding valve model has been reported. Affordability is an important factor that must be considered especially in developing nations. The aim of this review is to emphasize the advancement of tPVR, the benefits and challenges of valve implantation, the current state, and the future innovations associated with this approach.
机译:经导管肺动脉瓣置换术(tPVR)已发展成为可替代外科导管或生物瓣膜置换术的可行选择。该程序为先天性和结构性介入心脏病学的更高级方法铺平了道路。尽管已经取得了许多成功,但是这种手术仍然存在许多挑战,包括大型输送系统,需要导管或生物人工瓣膜作为瓣膜的着陆区,为防止右心室衰竭的最佳手术时机,心律不齐以及可能死亡。在治疗右心室流出道扩张的患者时,正在进行扩大该技术使用的研究,并且已经报道了自膨胀瓣膜模型的早期经验。可负担性是必须特别考虑在发展中国家中的重要因素。本文的目的是强调tPVR的发展,瓣膜植入的好处和挑战,这种方法的现状和未来的创新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号